Literature DB >> 21447778

Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.

Jennifer Permuth-Wey1, Y Ann Chen, Ya-Yu Tsai, Zhihua Chen, Xiaotao Qu, Johnathan M Lancaster, Heather Stockwell, Getachew Dagne, Edwin Iversen, Harvey Risch, Jill Barnholtz-Sloan, Julie M Cunningham, Robert A Vierkant, Brooke L Fridley, Rebecca Sutphen, John McLaughlin, Steven A Narod, Ellen L Goode, Joellen M Schildkraut, David Fenstermacher, Catherine M Phelan, Thomas A Sellers.   

Abstract

BACKGROUND: Mitochondria contribute to oxidative stress, a phenomenon implicated in ovarian carcinogenesis. We hypothesized that inherited variants in mitochondrial-related genes influence epithelial ovarian cancer (EOC) susceptibility.
METHODS: Through a multicenter study of 1,815 Caucasian EOC cases and 1,900 controls, we investigated associations between EOC risk and 128 single nucleotide polymorphisms (SNPs) from 22 genes/regions within the mitochondrial genome (mtDNA) and 2,839 nuclear-encoded SNPs localized to 138 genes involved in mitochondrial biogenesis (BIO, n = 35), steroid hormone metabolism (HOR, n = 13), and oxidative phosphorylation (OXP, n = 90) pathways. Unconditional logistic regression was used to estimate OR and 95% CI between genotype and case status. Overall significance of each gene and pathway was evaluated by using Fisher's method to combine SNP-level evidence. At the SNP level, we investigated whether lifetime ovulation, hormone replacement therapy (HRT), and cigarette smoking were confounders or modifiers of associations.
RESULTS: Interindividual variation involving BIO was most strongly associated with EOC risk (empirical P = 0.050), especially for NRF1, MTERF, PPARGC1A, ESRRA, and CAMK2D. Several SNP-level associations strengthened after adjustment for nongenetic factors, particularly for MTERF. Statistical interactions with cigarette smoking and HRT use were observed with MTERF and CAMK2D SNPs, respectively. Overall variation within mtDNA, HOR, and OXP was not statistically significant (empirical P > 0.10).
CONCLUSION: We provide novel evidence to suggest that variants in mitochondrial biogenesis genes may influence EOC susceptibility. IMPACT: A deeper understanding of the complex mechanisms implicated in mitochondrial biogenesis and oxidative stress may aid in developing strategies to reduce morbidity and mortality from EOC. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447778      PMCID: PMC3111851          DOI: 10.1158/1055-9965.EPI-10-1224

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  53 in total

Review 1.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 3.  Ovulatory factor in ovarian carcinogenesis.

Authors:  William J Murdoch
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 4.  Mitochondrial biogenesis and turnover.

Authors:  Francisca Diaz; Carlos T Moraes
Journal:  Cell Calcium       Date:  2008-04-18       Impact factor: 6.817

Review 5.  Transcriptional paradigms in mammalian mitochondrial biogenesis and function.

Authors:  Richard C Scarpulla
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 6.  Mitochondrial biogenesis and healthy aging.

Authors:  Guillermo López-Lluch; Pablo M Irusta; Placido Navas; Rafael de Cabo
Journal:  Exp Gerontol       Date:  2008-07-09       Impact factor: 4.032

Review 7.  Role of genetic polymorphisms and ovarian cancer susceptibility.

Authors:  Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Journal:  Mol Oncol       Date:  2009-02-04       Impact factor: 6.603

8.  Mitochondrial DNA polymorphism and risk of cancer.

Authors:  Keshav K Singh; Mariola Kulawiec
Journal:  Methods Mol Biol       Date:  2009

9.  Polymorphisms in mitochondrial genes and prostate cancer risk.

Authors:  Liang Wang; Shannon K McDonnell; Scott J Hebbring; Julie M Cunningham; Jennifer St Sauver; James R Cerhan; Grazia Isaya; Daniel J Schaid; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

10.  MITOMAP: a human mitochondrial genome database--2004 update.

Authors:  Marty C Brandon; Marie T Lott; Kevin Cuong Nguyen; Syawal Spolim; Shamkant B Navathe; Pierre Baldi; Douglas C Wallace
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

View more
  35 in total

1.  High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.

Authors:  Ivana Kurelac; Dario de Biase; Claudia Calabrese; Claudio Ceccarelli; Charlotte Ky Ng; Raymond Lim; Alan MacKay; Britta Weigelt; Anna Maria Porcelli; Jorge S Reis-Filho; Giovanni Tallini; Giuseppe Gasparre
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

Review 2.  Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.

Authors:  Pan Deng; Cole M Haynes
Journal:  Semin Cancer Biol       Date:  2017-05-10       Impact factor: 15.707

3.  Abruptio placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a candidate gene association study.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Bizu Gelaye; Timothy A Thornton; Fasil Tekola-Ayele; Sixto E Sanchez; Pedro J Garcia; Henry G Palomino; Anjum Hajat; Roberto Romero; Cande V Ananth; Michelle A Williams
Journal:  Am J Obstet Gynecol       Date:  2018-09-05       Impact factor: 8.661

4.  Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Authors:  Brett M Reid; Jennifer B Permuth; Y Ann Chen; Brooke L Fridley; Edwin S Iversen; Zhihua Chen; Heather Jim; Robert A Vierkant; Julie M Cunningham; Jill S Barnholtz-Sloan; Steven Narod; Harvey Risch; Joellen M Schildkraut; Ellen L Goode; Alvaro N Monteiro; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-04-04       Impact factor: 4.254

5.  MicroRNA-145 plays a role in mitochondrial dysfunction in alveolar epithelial cells in -induced acute respiratory distress syndrome.

Authors:  Yi Han; Su-Cheng Mu; Jian-Li Wang; Wei Wei; Ming Zhu; Shi-Lin Du; Min Min; Yun-Jie Xu; Zhen-Ju Song; Chao-Yang Tong
Journal:  World J Emerg Med       Date:  2021

Review 6.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

Review 7.  Mitochondria and cancer.

Authors:  Douglas C Wallace
Journal:  Nat Rev Cancer       Date:  2012-10       Impact factor: 60.716

8.  STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.

Authors:  Jennifer Permuth-Wey; William J Fulp; Brett M Reid; Zhihua Chen; Christina Georgeades; Jin Q Cheng; Anthony Magliocco; Dung-Tsa Chen; Johnathan M Lancaster
Journal:  Int J Cancer       Date:  2015-08-28       Impact factor: 7.396

Review 9.  Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.

Authors:  Kaumudi Bhawe; Deodutta Roy
Journal:  Cell Oncol (Dordr)       Date:  2018-07-25       Impact factor: 6.730

10.  Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.

Authors:  Brooke L Fridley; Gregory D Jenkins; Ya-Yu Tsai; Honglin Song; Kelly L Bolton; David Fenstermacher; Jonathan Tyrer; Susan J Ramus; Julie M Cunningham; Robert A Vierkant; Zhihua Chen; Y Ann Chen; Ed Iversen; Usha Menon; Aleksandra Gentry-Maharaj; Joellen Schildkraut; Rebecca Sutphen; Simon A Gayther; Lynn C Hartmann; Paul D P Pharoah; Thomas A Sellers; Ellen L Goode
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.